CMS extends Appropriate Use Criteria testing period until 2022
The Centers for Medicare & Medicaid Services today announced the extension of its Appropriate Use Criteria testing period through 2021.
This means the AUC program will not impact claims for diagnostic imaging services until Jan. 1, 2022, at the earliest.
The AHA has long advocated for an extension, including most recently in an AHA and American Medical Association joint letter in July. The letter stressed how the COVID-19 public health emergency has resulted in reduced imaging services, adding financial strains and prohibiting providers from sufficiently engaging in the AUC program’s preparatory steps; therefore, AHA is pleased to see CMS implement a delay to this program.
Related News Articles
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…